Casey R, Griffin T P, Wall D, Dennedy M C, Bell M, O'Shea P M
1 Department of Endocrinology, Centre of Diabetes, Endocrinology and Metabolism, Galway University Hospitals & Saolta Hospital Group, Galway, Ireland.
2 School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, Galway, Ireland.
Ann Clin Biochem. 2017 Jan;54(1):170-173. doi: 10.1177/0004563216646395. Epub 2016 Sep 28.
Background The Endocrine Society Clinical Practice Guideline on Phaeochomocytoma and Paraganglioma recommends phlebotomy for plasma-free metanephrines with patients fasted and supine using appropriately defined reference intervals. Studies have shown higher diagnostic sensitivities using these criteria. Further, with seated-sampling protocols, for result interpretation, reference intervals that do not compromise diagnostic sensitivity should be employed. Objective To determine the impact on diagnostic performance and financial cost of using supine reference intervals for result interpretation with our current plasma-free metanephrines fasted/seated-sampling protocol. Methods We conducted a retrospective cohort study of patients who underwent screening for PPGL using plasma-free metanephrines from 2009 to 2014 at Galway University Hospitals. Plasma-free metanephrines were measured using liquid chromatography-tandem mass spectrometry. Supine thresholds for plasma normetanephrine and metanephrine set at 610 pmol/L and 310 pmol/L, respectively, were used. Results A total of 183 patients were evaluated. Mean age of participants was 53.4 (±16.3) years. Five of 183 (2.7%) patients had histologically confirmed PPGL (males, n=4). Using seated reference intervals for plasma-free metanephrines, diagnostic sensitivity and specificity were 100% and 98.9%, respectively, with two false-positive cases. Application of reference intervals established in subjects supine and fasted to this cohort gave diagnostic sensitivity of 100% with specificity of 74.7%. Financial analysis of each pretesting strategy demonstrated cost-equivalence (€147.27/patient). Conclusion Our cost analysis, together with the evidence that fasted/supine-sampling for plasma-free metanephrines, offers more reliable exclusion of PPGL mandates changing our current practice. This study highlights the important advantages of standardized diagnostic protocols for plasma-free metanephrines to ensure the highest diagnostic accuracy for investigation of PPGL.
内分泌学会关于嗜铬细胞瘤和副神经节瘤的临床实践指南建议,在患者禁食并仰卧时,采用适当定义的参考区间进行血浆游离甲氧基肾上腺素的静脉穿刺采血。研究表明,使用这些标准可获得更高的诊断敏感性。此外,对于坐位采样方案,在结果解释时应采用不影响诊断敏感性的参考区间。目的:确定在我们目前的血浆游离甲氧基肾上腺素禁食/坐位采样方案中,使用仰卧位参考区间进行结果解释对诊断性能和财务成本的影响。方法:我们对2009年至2014年在戈尔韦大学医院使用血浆游离甲氧基肾上腺素进行嗜铬细胞瘤和副神经节瘤筛查的患者进行了一项回顾性队列研究。采用液相色谱-串联质谱法测定血浆游离甲氧基肾上腺素。血浆去甲氧基肾上腺素和甲氧基肾上腺素的仰卧位阈值分别设定为610 pmol/L和310 pmol/L。结果:共评估了183例患者。参与者的平均年龄为53.4(±16.3)岁。183例患者中有5例(2.7%)经组织学证实为嗜铬细胞瘤和副神经节瘤(男性,n = 4)。使用血浆游离甲氧基肾上腺素的坐位参考区间,诊断敏感性和特异性分别为100%和98.9%,有2例假阳性病例。将在仰卧位和禁食状态下建立的参考区间应用于该队列,诊断敏感性为100%,特异性为74.7%。对每种检测前策略的财务分析表明成本相当(147.27欧元/患者)。结论:我们的成本分析以及血浆游离甲氧基肾上腺素禁食/仰卧位采样能更可靠地排除嗜铬细胞瘤和副神经节瘤的证据,要求改变我们目前的做法。本研究强调了血浆游离甲氧基肾上腺素标准化诊断方案的重要优势,以确保嗜铬细胞瘤和副神经节瘤调查的最高诊断准确性。